Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP) - 02/09/11
Doi : 10.1067/mjd.2001.103644
Abstract |
Photochemotherapy with psoralens and UVA (PUVA) is widely used in the treatment of psoriasis and many other skin conditions. Cutaneous adverse reactions to 8-methoxypsoralen (8-MOP) appear to be rare and may be difficult to distinguish from phototoxicity or UV-induced polymorphic light eruption. We describe a patient who had a systemic allergic contact dermatitis to 8-MOP develop during her second course of PUVA treatment for psoriasis. (J Am Acad Dermatol 2001;45:S218-9.)
Il testo completo di questo articolo è disponibile in PDF.Mappa
 | This supplement is made possible through an unrestricted educational grant from Stiefel Laboratories to the American Academy of Dermatology. |
| Reprint requests: Jane Ravenscroft, MBChB MRCP, Department of Dermatology, Queens Medical Centre, Clifton Boulevard, Nottingham, N97 2UH, England. E-mail: ravo@compuserve.com. |
© 2001
American Academy of Dermatology, Inc. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 45 - N° 6S
P. S218-S219 - dicembre 2001 Ritorno al numero
Articolo precedente
- Necrotizing vasculitis in a patient with generalized morphea
- Akimichi Morita, Takuo Tsuji
- Mesalazine-induced pustular drug eruption
- Karen L. Gibbon, Anthony P. Bewley, Kathleen Thomas
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?